Pdt Partners, LLC Tango Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1 Billion
Q4 2024

A detailed history of Pdt Partners, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 102,807 shares of TNGX stock, worth $206,642. This represents 0.03% of its overall portfolio holdings.

Number of Shares

102,807

Holding current value

$206,642

% of portfolio

0.03%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 14, 2025	BUY	$2.79 - $7.46 $286,831 - $766,940	102,807 New	102,807 $317,000
Q2 2023 Aug 14, 2023	BUY	$2.67 - $4.7 $37,350 - $65,748	13,989 New	13,989 $46,000

Others Institutions Holding TNGX

# of Institutions

138

Shares Held

91.1M

Call Options Held

1.4K

Put Options Held

4.4K

Trv Gp Iv, LLC Boston, MA

16.9M
Shares

$33.9 Million
64.97% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

10.7M
Shares

$21.6 Million
5.42% of portfolio
Eco R1 Capital, LLC San Francisco, CA

10.6M
Shares

$21.4 Million
1.53% of portfolio
Nextech Invest Ag

5.53M
Shares

$11.1 Million
3.19% of portfolio
Farallon Capital Management LLC San Francisco, CA

4M
Shares

$8.04 Million
0.07% of portfolio

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $177M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account